drugset / Trial / NCT06695195

A Randomized Controlled Trial of Oral CBD for the Treatment of Upper Extremity Musculoskeletal Pain

NCT06695195

Phase 1 Not yet recruiting 100 enrolled Brent DeGeorge The Plastic Surgery Foundation · collab
RandomizedCrossoverQuadruple-blindTreatment

Summary

The goal of this clinical trial is to learn about the use of cannabidiol (CBD) capsules as a treatment for musculoskeletal pain. CBD is commonly being used as an over-the-counter treatment for musculoskeletal pain. Clinical trials have demonstrated a pain-relief benefit for hand and wrist osteoarthritis with topical CBD, however patients prefer oral CBD and no clinical trial has been performed to establish efficacy of oral CBD in humans for upper extremity musculoskeletal pain. The main questions it aims to answer are: Is CBD more effective than placebo at relieving pain for upper extremity musculoskeletal pain ? Is CBD safe for participants with upper extremity musculoskeletal pain? Participants will: take 4 weeks of daily CBD capsules take 4 weeks of daily placebo capsules answer surveys about how they are feeling and functioning. Participants will \[describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items\].

Timeline

Start
2025-06
Primary completion
2026-03
Completion
2026-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 25 mg Oral

Indications

No indication recorded.